The open index of psychedelic research

The “dark magic mushroom” co-produces amatoxins and psilocybin

Kunik AR, Christopher MW, Lemmond B +4

Esketamine as an Adjuvant to Levobupivacaine in Thoracic Paravertebral Block for Thoracoscopic Lung Cancer Surgery: A Retrospective Propensity Score-Matched Cohort Study.

Jing Y, Jiang X, Hu B +3

Esketamine in Treatment-Resistant Depression: Clinical and Translational Perspectives.

Śledzikowska Z, Pasternak AM, Wojciechowski K +1

Ketamine persists within neuronal compartments long after systemic clearance

Cichon J, Bera K, Blumenfeld Z +16

MDMA restores cortico-accumbal signaling and rescues autism-related social deficits.

Llorach, Pierre, Kodali, Anish, Hertweck, Caroline +4

In silico insights into the adsorption and detection of dimethyltryptamine on metal doped C<sub>20</sub> fullerene.

Sumayli A, Alshahrani SM, Alamoudi JA

Validation of the Crosswise Model for Psychedelic Use

Effect of opioid-free anesthesia on postoperative recovery in elderly patients undergoing laparoscopic abdominal surgery: a randomized controlled trial.

Zhao Q, Wang Y, Huang F +2

Psilocybin as serotonergic therapy in epilepsy: Narrative review of potentials and limitations.

Cervera-Sanchez MB, San-Juan D, Díaz-Peregrino R +3

Quality of life and productivity among esketamine responders in a real-world study in Australia and New Zealand.

Hopwood M, Codyre D, Barton D +4

Targeting TLR4/PPARα-mediated neuroinflammation in the prefrontal cortex: S-ketamine and S-HNK rapidly alleviate depression-like behaviors.

Zhu Q, Zhou X, Gao H +2

Psilocybin asymmetrically modulates outcome-based choice and cortical processing under uncertainty

Jacobs DS, Pacheco AT, Olson R +2

Role of perioperative ketamine on the incidence of rebound pain after regional nerve block in the adult surgical population: A systematic review and meta-analysis of randomised controlled trials.

Makkar JK, Khurana BJK, Singh PM +1

Reconstituting a two-step pathway for <i>N</i>,<i>N</i>-dimethyltryptamine (DMT) biosynthesis in bacteria.

Junges LH, Pontes FLD, Mota FJT +4

Social hierarchy shapes behavioral and transcriptional responses to chronic stress and ketamine in male mice.

Gasperoni S, Ji X, Sudre-Chinsky C +11

Editorial: Emerging treatment approaches for substance use disorders.

Martinez Garza D, Blokhin IO, Brett J +1

Design of a new psychedelic quipazine analog with therapeutic efficacy and potentially fewer side effects.

Younkin J, Bansode AH, Saha S +21

At-Home Telehealth-Supported Subcutaneous Ketamine Therapy for Safety, Feasibility, and Clinical Outcomes in Adults With Moderate to Severe Depression, Anxiety, or Posttraumatic Stress Disorder in a Large, Heterogeneous Cohort in the United States: Retrospective Cohort Study.

Parks AC, Woodward AL, Henry RD +4

Sustained abstinence in severe ketamine use disorder following ibogaine treatment case report.

Pérez Rosal SR, Faber SC, Backmund M

Learnings from a hybrid communities of practice group therapy model to support psilocybin-assisted therapy for patients with a terminal diagnosis.

Tsang VW, Kryskow P, Watler C +2

Psychedelic-occasioned mystical experience as a candidate operationalization of the spiritual dimension of osteopathic care, with application to body dysmorphic disorder: a scoping review protocol

Safety, Therapeutic Potential, and Mechanisms of Two Psilocybin Doses, Administered With Psychological Support in Young Adults With Anorexia Nervosa

Effects of low-dose esketamine on postoperative pain, sleep quality, and inflammatory response after elective cesarean section: a randomized, double-blind, placebo-controlled trial

Liu S, Mou B, Cai C +7

Antidepressant-like effects of ketamine involve CX<sub>3</sub>CL1/CX<sub>3</sub>CR1 signaling-mediated synaptic plasticity in the mPFC.

Yin YY, Sun SR, Zhang HY +4